While opium use has been identified as the main drug problem in Iran for centuries, since a decade ago the country has encountered an emerging trend of stimulant use.
The main stimulant of use in Iran is methamphetamine – a potent psychostimulant drug which its use is associated with increased risk of HIV transmission, psychosis and cardiovascular problem and stroke.
In line with this, piloting prevention programmes for amphetamine users has been included in the HIV/AIDS New Funding Model of the Global Fund. One of the activities under this initiative was the organization of training workshops, one of which is currently being held in Ahvaz from 23 to 25 February.
The workshop’s focus is on the harm reduction services for amphetamine users. This event is being held in cooperation with the University of Medical Sciences, Mental Health, Social Health, Addiction Office of Ministry of Health and Medical Education and with financial support of the Global Fund.
The workshop is attended by 70 participants – technical officers of universities and managers of Drop-In-Centres (DIC) – from 21 universities of medicals sciences namely: Shahid Beheshti, Tehran, Qazvin, Isfahan, Mashhad, Alborz, Ahvaz, Kerman, Kermanshah, Abadan, Behbahan, Dezfool, Sanandaj, Shiraz, Qom, Kohkiloye va Boyerahmad, Lorestan, Mazandaran, Hormozgan and Yazd.